Advertisement

Table of Contents

March 03, 2016; 127 (9)

ANNIVERSARY EDITORIAL

BLOOD FLASHBACK

INSIDE BLOOD COMMENTARIES

PLENARY PAPER

BLOOD SPOTLIGHT

CLINICAL TRIALS AND OBSERVATIONS

  • Triplet vs doublet lenalidomide-containing regimens for the treatment of elderly patients with newly diagnosed multiple myeloma
    Valeria Magarotto, Sara Bringhen, Massimo Offidani, Giulia Benevolo, Francesca Patriarca, Roberto Mina, Antonietta Pia Falcone, Lorenzo De Paoli, Giuseppe Pietrantuono, Silvia Gentili, Caterina Musolino, Nicola Giuliani, Annalisa Bernardini, Concetta Conticello, Stefano Pulini, Giovannino Ciccone, Vladimír Maisnar, Marina Ruggeri, Renato Zambello, Tommasina Guglielmelli, Antonio Ledda, Anna Marina Liberati, Vittorio Montefusco, Roman Hajek, Mario Boccadoro and Antonio Palumbo
  • Melphalan, prednisone, and lenalidomide versus melphalan, prednisone, and thalidomide in untreated multiple myeloma
    Sonja Zweegman, Bronno van der Holt, Ulf-Henrik Mellqvist, Morten Salomo, Gerard M. J. Bos, Mark-David Levin, Heleen Visser-Wisselaar, Markus Hansson, Annette W. G. van der Velden, Wendy Deenik, Astrid Gruber, Juleon L. L. M. Coenen, Torben Plesner, Saskia K. Klein, Bea C. Tanis, Damian L. Szatkowski, Rolf E. Brouwer, Matthijs Westerman, M. (Rineke) B. L. Leys, Harm A. M. Sinnige, Einar Haukås, Klaas G. van der Hem, Marc F. Durian, E. (Vera) J. M. Mattijssen, Niels W. C. J. van de Donk, Marian J. P. L. Stevens-Kroef, Pieter Sonneveld and Anders Waage

IMMUNOBIOLOGY

  • Ibrutinib enhances chimeric antigen receptor T-cell engraftment and efficacy in leukemia
    Joseph A. Fraietta, Kyle A. Beckwith, Prachi R. Patel, Marco Ruella, Zhaohui Zheng, David M. Barrett, Simon F. Lacey, Jan Joseph Melenhorst, Shannon E. McGettigan, Danielle R. Cook, Changfeng Zhang, Jun Xu, Priscilla Do, Jessica Hulitt, Sagar B. Kudchodkar, Alexandria P. Cogdill, Saar Gill, David L. Porter, Jennifer A. Woyach, Meixiao Long, Amy J. Johnson, Kami Maddocks, Natarajan Muthusamy, Bruce L. Levine, Carl H. June, John C. Byrd and Marcela V. Maus

LYMPHOID NEOPLASIA

MYELOID NEOPLASIA

  • LIN28B overexpression defines a novel fetal-like subgroup of juvenile myelomonocytic leukemia
    Hetty H. Helsmoortel, Silvia Bresolin, Tim Lammens, Hélène Cavé, Peter Noellke, Aurélie Caye, Farzaneh Ghazavi, Andrica de Vries, Henrik Hasle, Veerle Labarque, Riccardo Masetti, Jan Stary, Marry M. van den Heuvel-Eibrink, Jan Philippé, Nadine Van Roy, Yves Benoit, Frank Speleman, Charlotte Niemeyer, Christian Flotho, Giuseppe Basso, Geertruy te Kronnie, Pieter Van Vlierberghe and Barbara De Moerloose
  • Targeting acute myeloid leukemia with a small molecule inhibitor of the Myb/p300 interaction
    Sagar Uttarkar, Emilie Dassé, Anna Coulibaly, Simone Steinmann, Anke Jakobs, Caroline Schomburg, Amke Trentmann, Joachim Jose, Peter Schlenke, Wolfgang E. Berdel, Thomas J. Schmidt, Carsten Müller-Tidow, Jon Frampton and Karl-Heinz Klempnauer

PLATELETS AND THROMBOPOIESIS

THROMBOSIS AND HEMOSTASIS

  • von Willebrand factor is dimerized by protein disulfide isomerase
    Svenja Lippok, Katra Kolšek, Achim Löf, Dennis Eggert, Willem Vanderlinden, Jochen P. Müller, Gesa König, Tobias Obser, Karoline Röhrs, Sonja Schneppenheim, Ulrich Budde, Carsten Baldauf, Camilo Aponte-Santamaría, Frauke Gräter, Reinhard Schneppenheim, Joachim O. Rädler and Maria A. Brehm
  • A novel role for von Willebrand factor in the pathogenesis of experimental cerebral malaria
    Niamh O’Regan, Kristina Gegenbauer, Jamie M. O’Sullivan, Sanaz Maleki, Teresa M. Brophy, Niall Dalton, Alain Chion, Padraic G. Fallon, Georges E. Grau, Ulrich Budde, Owen P. Smith, Alister G. Craig, Roger J. S. Preston and James S. O’Donnell

TRANSPLANTATION

LETTERS TO BLOOD

BLOOD WORK